Geocann is introducing a new 4-in-1 immune health formulation that combines the benefits of curcumin (50 mg), cannabidiol (15 mg; CBD), beta-caryophyllene (7 mg; BCP), and vitamin D3 (200 IU).
Geocann (Fort Collins, CO) is introducing a new 4-in-1 immune health formulation that combines the benefits of curcumin (50 mg), cannabidiol (15 mg; CBD), beta-caryophyllene (7 mg; BCP), and vitamin D3 (200 IU). The formula utilizes the patented VESIsorb drug delivery system which optimizes absorption and bioavailability of the ingredients, known for their low bioavailability.
“These ingredients have been strategically selected for their immunity support and anti-inflammatory properties, but are notorious for showing limited bioavailability due to their lipophilicity and extensive first-pass metabolism,” said Anthony Petraglia, MD, chief medical officer for Geocann, in a press release. “With a successful track record over the past fifteen years, VESIsorb has consistently demonstrated its ability to mitigate these negative effects while significantly improving the pharmacokinetic performance of natural ingredients. To put it simply, bioavailability is the key to providing an immunity support product that delivers its desired health benefits.”
“Geocann has a strategic focus to deliver cannabinoid and terpene products with an unmatched body of supporting scientific evidence that address the most pressing health concerns,” said Sam Davidson, chief operating officer. “The marketplace demand for natural immunity support products is unprecedented, and the relationship between a healthy immune system and a strong endocannabinoid system (ECS) is well-documented. More than ever, we are committed to pioneering these innovative solutions with our technical formulation expertise, rigorous product development protocol, and global distribution infrastructure.”